These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 25196651)

  • 21. A case of erythrokeratodermia variabilis with connexin 31 gene mutation (Cx31F137L).
    Torres T; Velho G; Sanches M; Selores M
    Int J Dermatol; 2012 Apr; 51(4):494-6. PubMed ID: 21913904
    [No Abstract]   [Full Text] [Related]  

  • 22. A missense mutation in the GJB3 gene responsible for erythrokeratodermia variabilis in a Chinese family.
    Wang W; Liu LH; Chen G; Gao M; Zhu J; Zhou FS; Cheng H; Tang HY; Wu BY; Sun LD; Yang S; Wang PG; Zhang XJ
    Clin Exp Dermatol; 2012 Dec; 37(8):919-21. PubMed ID: 22681493
    [No Abstract]   [Full Text] [Related]  

  • 23. Erythrokeratodermia variabilis with hypertrichosis on the lesions.
    Wu JP; Ge HS; Yang C
    Chin Med J (Engl); 2020 Feb; 133(4):501-502. PubMed ID: 31977560
    [No Abstract]   [Full Text] [Related]  

  • 24. A novel GJB3 (Cx31) missense mutation in a Chinese patient with erythrokeratodermia variabilis.
    Wang ZX; Lu WS; Li H; Lin D; Zhou FS; Sun LD; Yang S; Zhang XJ
    J Eur Acad Dermatol Venereol; 2011 Jan; 25(1):113-5. PubMed ID: 20497287
    [No Abstract]   [Full Text] [Related]  

  • 25. Erythrokeratodermia variabilis.
    Strober BE
    Dermatol Online J; 2003 Oct; 9(4):5. PubMed ID: 14594578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erythrokeratodermia variabilis: Two case reports.
    Karadag AS; Bilgili SG; Calka O; Bayram I
    Indian Dermatol Online J; 2013 Oct; 4(4):340-3. PubMed ID: 24350021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for the absence of mutations at GJB3, GJB4 and LOR in progressive symmetrical erythrokeratodermia.
    Wei S; Zhou Y; Zhang TD; Huang ZM; Zhang XB; Zhu HL; Liang BH; Lin L; Deng L
    Clin Exp Dermatol; 2011 Jun; 36(4):399-405. PubMed ID: 21198793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incompletely penetrant TRPM4-associated progressive symmetric erythrokeratodermia responses to methotrexate.
    Jiang X; Wang Z; Lin Z; Xu Z; Wang H
    J Dermatol; 2022 Nov; 49(11):e422-e423. PubMed ID: 35796031
    [No Abstract]   [Full Text] [Related]  

  • 29. Visual diagnosis: a 10-year-old boy with a persistent rash since birth.
    Tuli S; Tuli S
    Pediatr Rev; 2011 Nov; 32(11):e102-4. PubMed ID: 22045901
    [No Abstract]   [Full Text] [Related]  

  • 30. MEDNIK-like syndrome due to compound heterozygous mutations in AP1B1.
    Ito Y; Takeichi T; Igari S; Mori T; Ono A; Suyama K; Takeuchi S; Muro Y; Ogi T; Hosoya M; Yamamoto T; Akiyama M
    J Eur Acad Dermatol Venereol; 2021 May; 35(5):e345-e347. PubMed ID: 33349978
    [No Abstract]   [Full Text] [Related]  

  • 31. Expanding the clinical phenotype associated with ELOVL4 mutation: study of a large French-Canadian family with autosomal dominant spinocerebellar ataxia and erythrokeratodermia.
    Cadieux-Dion M; Turcotte-Gauthier M; Noreau A; Martin C; Meloche C; Gravel M; Drouin CA; Rouleau GA; Nguyen DK; Cossette P
    JAMA Neurol; 2014 Apr; 71(4):470-5. PubMed ID: 24566826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythrokeratodermia variabilis. A family study.
    Gewirtzman GB; Winkler NW; Dobson RL
    Arch Dermatol; 1978 Feb; 114(2):259-61. PubMed ID: 147057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case of erythrokeratodermia figurata variabilis successfully treated with tigason].
    Magyarlaki M; Drobnitsch I; Zombai E; Schneider I
    Z Hautkr; 1989 Oct; 64(10):881-2, 885-7. PubMed ID: 2531508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erythrokeratoderma variabilis successfully treated with topical tazarotene.
    Yoo S; Simzar S; Han K; Takahashi S; Cotliar R
    Pediatr Dermatol; 2006; 23(4):382-5. PubMed ID: 16918639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erythrokeratodermia variabilis with adult onset: report of a sporadic case unresponsive to systemic retinoids.
    Erbagci Z; Tuncel AA; Deniz H
    J Dermatolog Treat; 2006; 17(3):187-9. PubMed ID: 16854764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erythrokeratodermia variabilis in a patient followed through the first year of life.
    Bond MJ; Donelan P; Fenske N
    Cutis; 1982 Nov; 30(5):633-7. PubMed ID: 7172743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of erythrokeratodermia variabilis with oral synthetic retinoids.
    Fixler ZC
    Cutis; 1980 Mar; 25(3):300-4. PubMed ID: 6444572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erythrokeratodermia variabilis treated with isotretinoin. A clinical, histologic, and ultrastructural study.
    Rappaport IP; Goldes JA; Goltz RW
    Arch Dermatol; 1986 Apr; 122(4):441-5. PubMed ID: 2420287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythrokeratodermia progressivum symmetricum.
    Mittal RR; Bansal N
    Indian J Dermatol Venereol Leprol; 1998; 64(3):126-7. PubMed ID: 20921738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Familial coexistence of erythrokeratodermia variabilis and keratosis palmoplantaris transgrediens et progrediens].
    Wollina U; Knopf B; Schaaschmidt H; Frille I
    Hautarzt; 1989 Mar; 40(3):169-72. PubMed ID: 2523877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.